Active Psychology & Behaviour Brain & Nervous System

Functional heterogeneity in the prefrontal cortex of adult and developing marmosets: insight into the individual variation in depression and its symptoms

In plain English

AI plain-English summary

Depression treatments fail for many patients because the brain’s prefrontal cortex contains distinct subregions that contribute to different symptoms—sadness, anhedonia, biased decision-making, and helplessness—yet current therapies treat them all the same. This project uses marmosets, a non-human primate, to map those subregions one by one. The researchers will temporarily activate or silence specific prefrontal areas using chemogenetics, then measure how each manipulation alters behaviour on computerised cognitive tests and changes brain activity on PET and functional MRI scans. They will also perform the same interventions during adolescence, when depression often first emerges, to identify developmental windows of vulnerability. If the work succeeds, it could allow clinicians to match a patient’s dominant symptom cluster—say, anhedonia versus negative bias—to a targeted brain region for stimulation or medication, rather than prescribing the same antidepressant for everyone. The project also establishes new tools for studying social behaviour in marmosets, which is relevant because social withdrawal is a core feature of depression. This is fundamental science: it aims to understand causal brain circuits, not to test a therapy.

View original technical description
The overarching goal is to determine the functional heterogeneity within prefrontal cortex contributing to individual variation in the aetiology and treatment of key symptoms of major depressive disorder (MDD) including sadness, anhedonia (social and non-social), negatively biased decision making and lack of control/helplessness. Insights gained should facilitate refinement of individual diagnosis and treatment strategies. Key prefrontal regions in which altered activity is linked to MDD and its treatment will be targeted in a non-human primate, common marmosets. Specifically, acute chemogenetic activation/inactivation of these regions will determine (i) the relationship of the lateral orbitofrontal cortex to reward loss and disappointment/sadness, (ii) the contribution of the dorsolateral prefrontal cortex to conflict in decision making and negative bias, (iii) the involvement of the pregenual cingulate cortex in the ability to control environmental events. Behaviour and cardiovascular activity will be measured across multiple computerized cognitive tests and PET/functional MRI will assess distributed effects on circuit activity. With MDD onset associated with adolescence, acute regional interventions during adolescence will identify windows of perturbational vulnerability, whilst multi-parametric MRI will provide neurocircuit developmental insights. Foundational work on marmoset social development will establish novel toolsets for applying our approach in the social domain; highly relevant to MDD onset.

View the original record at the funder ↗

Researchers

Angela Roberts (EPMC Awardee)

Related Research

Grants with similar aims, by meaning.

Non-human primate investigations into hippocampal and prefrontal contributions to the cognitive dysfunction apparent in schizophrenia
Characterising the neurocomputational basis of motivated behaviour in anhedonic depression
The neurobiology of cognitive affective biases in depression and their role in antidepressant therapy
Psychological, pharmacological and developmental insights into the prefrontal circuits underlying threat regulation and negative bias in marmosets
Hippocampal-dorsolateral prefrontal interactions and cognitive dysfunction in schizophrenia: A non-human primate model

Original classification

Investigator Award in Science

Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research.